PubMed Health⌕ Search

PubMed · 360958

Coronary bypass surgery. An overview.

Abstract

During the ten year history of coronary bypass surgery the initially unacceptable high operative mortality has dropped to 1--2%. Of the twin targets of the procedure, alleviation of disabling angina and improvement in the prognosis, the former seems to have been achieved and is universally accepted. Several series with repeated exercise tests show that about 70% of the patients gain definite benefit; a high proportion of these patients become entirely asymptomatic. Reestablishment of effective coronary perfusion via the grafts seems to be the key factor in this response. However, several other factors, such as perioperative infarction, psychogenic effects, cardiac denervation, and changes in left ventricular function, are also involved. There is still disagreement about the effect of bypass surgery on life expectancy. It is not, in fact, known with certainty whether prognosis is improved, although coronary bypass surgery does not appear to be inferior to medical management in terms of prolonging life span. It has also been established that there is an improvement in prognosis after bypass surgery for patients with obstruction of the left main coronary artery, while the fairy favourable prognosis of patients with single vessel disease can hardly be improved. Available data from randomized series consisting of the whole range of patients with coronary heart disease are either quantitatively or qualitatively insufficient by present standards. Accordingly, new data will eventually afford the evidence needed for drawing firm conclusions about the final value of coronary bypass surgery in improving the prognosis of coronary heart disease.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M H Frick. 1978. Coronary bypass surgery. An overview.. https://pubmed.ncbi.nlm.nih.gov/360958/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effect of a hypoglycemic agent on ischemic preconditioning in patients with type 2 diabetes and stable angina pectoris.

OBJECTIVE: Ischemic preconditioning is an increased tolerance to myocardial ischemia during the second of two consecutive exercise tests. ATP-sensitive K(+) channel blockers, such as glinides and sulfonylurea drugs, can induce loss of ischemic preconditioning. This study aimed to investigate the effects of repaglinide, a hypoglycemic agent with an affinity for myocardial ATP-sensitive K (+)channels, on the results of consecutive exercise tests in patients with diabetes and multivessel coronary artery disease. METHODS: Forty-two patients with type 2 diabetes and chronic stable angina pectoris, and two-vessel or three-vessel disease participated in this study. The patients underwent two consecutive treadmill exercise tests (phase 1). On the day after these exercise tests, 2 mg of oral repaglinide was given to the patients. One week later, two exercise tests were repeated consecutively (phase 2). RESULTS: All patients achieved 1.0-mm ST-segment depression during the four exercise tests (T1, T2, T3, and T4). In phase 2, seven patients improved in time to onset of 1.0-mm ST-segment depression. The worsening of the time to onset of 1.0-mm ST-segment depression in phase 2 demonstrated ischemic preconditioning block in 83.3% of patients (P=0.0001). Even the postexercise electrocardiographic parameters (ST-segment depression morphology and magnitude and arrhythmias) were significantly different between the groups with and without pharmacologic ischemic preconditioning block (P=0.031). CONCLUSIONS: Repaglinide, an oral hypoglycemic agent with ATP-sensitive K(+) channel-blocker activity, eliminated the myocardial ischemic preconditioning in patients with coronary disease and diabetes.

Angina Pectoris↗